Bilimsel Makale Arama | NeuralCipher AI

Kaynak kaydı

Palliative and end of life care for people with dementia: lessons for clinical commissioners.

Raymond M, Warner A, Davies N, Nicholas N, Manthorpe J, Iliffe S.

Prim Health Care Res Dev · 2013-11-26

DOI: 10.1017/s146342361300039xPMID: 24280024

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Effect of moderate liver impairment on the pharmacokinetics of opicapone.

Rocha JF, Santos A, Falcão A, Lopes N, Nunes T, Pinto R, Soares-da-Silva P.

Eur J Clin Pharmacol · 2013-11-24

DOI: 10.1007/s00228-013-1602-9PMID: 24271646

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Efficacy of levodopa/carbidopa/entacapone versus levodopa/carbidopa in patients with early Parkinson's disease experiencing mild wearing-off: a randomised, double-blind trial.

Tolosa E, Hernández B, Linazasoro G, López-Lozano JJ, Mir P, Marey J, Kulisevsky J.

J Neural Transm (Vienna) · 2013-11-20

DOI: 10.1007/s00702-013-1114-xPMID: 24253234

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Clinical subtypes in Parkinson's disease: the impact of MAPT haplotypes.

Di Battista ME, Pascale E, Purcaro C, Passarelli F, Passarelli E, Guglielmi R, Vanacore N, Meco G.

J Neural Transm (Vienna) · 2013-11-20

DOI: 10.1007/s00702-013-1117-7PMID: 24253235

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Controlled general anaesthesia for subthalamic nucleus stimulation in Parkinson's disease.

Fluchere F, Witjas T, Eusebio A, Bruder N, Giorgi R, Leveque M, Peragut JC, Azulay JP, Regis J.

J Neurol Neurosurg Psychiatry · 2013-11-18

DOI: 10.1136/jnnp-2013-305323PMID: 24249783

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Proprioception: where are we now? A commentary on clinical assessment, changes across the life course, functional implications and future interventions.

Suetterlin KJ, Sayer AA.

Age Ageing · 2013-11-14

DOI: 10.1093/ageing/aft174PMID: 24231586

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Impact of physical exercise on reaction time in patients with Parkinson's disease-data from the Berlin BIG Study.

Ebersbach G, Ebersbach A, Gandor F, Wegner B, Wissel J, Kupsch A.

Arch Phys Med Rehabil · 2013-11-11

DOI: 10.1016/j.apmr.2013.10.020PMID: 24231400

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial.

Devos D, Moreau C, Maltête D, Lefaucheur R, Kreisler A, Eusebio A, Defer G, Ouk T, Azulay JP, Krystkowiak P, Witjas T, Delliaux M, Destée A, Duhamel A, Bordet R, Defebvre L, Dujardin K.

J Neurol Neurosurg Psychiatry · 2013-11-11

DOI: 10.1136/jnnp-2013-306439PMID: 24218528

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Brain activity during complex imagined gait tasks in Parkinson disease.

Peterson DS, Pickett KA, Duncan RP, Perlmutter JS, Earhart GM.

Clin Neurophysiol · 2013-11-05

DOI: 10.1016/j.clinph.2013.10.008PMID: 24210997

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Leg muscle power is enhanced by training in people with Parkinson's disease: a randomized controlled trial.

Paul SS, Canning CG, Song J, Fung VS, Sherrington C.

Clin Rehabil · 2013-11-04

DOI: 10.1177/0269215513507462PMID: 24188914

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Spinopelvic balance: new biomechanical insights with clinical implications for Parkinson's disease.

Bissolotti L, Gobbo M, Villafañe JH, Negrini S.

Eur Spine J · 2013-10-27

DOI: 10.1007/s00586-013-3068-yPMID: 24162521

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

60-Hz frequency effect on gait in Parkinson's disease with subthalamic nucleus deep brain stimulation.

Phibbs FT, Arbogast PG, Davis TL.

Neuromodulation · 2013-10-24

DOI: 10.1111/ner.12131PMID: 24165197

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.

7.691 makale bulundu

Palliative and end of life care for people with dementia: lessons for clinical commissioners.

Effect of moderate liver impairment on the pharmacokinetics of opicapone.

Efficacy of levodopa/carbidopa/entacapone versus levodopa/carbidopa in patients with early Parkinson's disease experiencing mild wearing-off: a randomised, double-blind trial.

Clinical subtypes in Parkinson's disease: the impact of MAPT haplotypes.

Controlled general anaesthesia for subthalamic nucleus stimulation in Parkinson's disease.

Proprioception: where are we now? A commentary on clinical assessment, changes across the life course, functional implications and future interventions.

Impact of physical exercise on reaction time in patients with Parkinson's disease-data from the Berlin BIG Study.

Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial.

Brain activity during complex imagined gait tasks in Parkinson disease.

Leg muscle power is enhanced by training in people with Parkinson's disease: a randomized controlled trial.

Spinopelvic balance: new biomechanical insights with clinical implications for Parkinson's disease.

60-Hz frequency effect on gait in Parkinson's disease with subthalamic nucleus deep brain stimulation.

Filtreler